Armstrong Pharma Acquired by Medeva
TM Capital advised Armstrong Pharmaceuticals, Inc. (NASDAQ) in completing its $52 million stock swap merger with Medeva plc (LSE)
Immucor Goodwill Valuation Analysis
TM Capital provided Immucor, Inc. (NASDAQ) with an analysis of goodwill balances for potential impairment pursuant to FAS 142
SteriGenics Acquired by IBA
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash
Industrial Defender Recapitalization
TM Capital advised the Special Committee of the Board of Directors of Industrial Defender, Inc. on the Company’s recapitalization from existing investors
CompuCredit Corporation
TM Capital provided financial advisory services to CompuCredit Corporation (NASDAQ)
Resolute Acquires Remaining Fibrek Shares
TM Capital acted as financial advisor to the independent members of the Board of Fibrek on its proposed Arrangement to amalgamate with Resolute Forest Products Inc.
Medical Diagnostics Acquired by ANMR
TM Capital completed the $29 million sale of Medical Diagnostics, Inc. (NASDAQ) to Advanced NMR Systems Inc. (NASDAQ) following an unsolicited tender offer by Raytel Medical Corp. (NASDAQ)
Reinhold Declares Special Dividend
TM Capital advised Reinhold Industries, Inc. (NASDAQ) in declaring a $19.6 million shareholder distribution
Graham Corporation Adopts Rights Plan
TM Capital assisted the Board of Directors of Graham Corporation (AMEX) in adopting a shareholder’s rights plan
Oceanaire Completes Equity Financing
TM Capital advised the Special Committee of the Board of Directors of The Oceanaire, Inc. on the Company’s private placement to existing investors led by Clarion Capital Partners